1. Home
  2. BCDA vs ILAG Comparison

BCDA vs ILAG Comparison

Compare BCDA & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.27

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

HOLD

Current Price

$0.42

Market Cap

9.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
ILAG
Founded
N/A
1981
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
9.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BCDA
ILAG
Price
$1.27
$0.42
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
70.4K
39.8K
Earning Date
11-12-2025
12-22-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,338,785.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.27
52 Week High
$3.20
$0.98

Technical Indicators

Market Signals
Indicator
BCDA
ILAG
Relative Strength Index (RSI) 41.88 44.26
Support Level $1.23 $0.27
Resistance Level $1.34 $0.50
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.01
Stochastic Oscillator 17.86 51.13

Price Performance

Historical Comparison
BCDA
ILAG

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

Share on Social Networks: